223 related articles for article (PubMed ID: 1584174)
1. A brief history of parkinsonism.
Duvoisin RC
Neurol Clin; 1992 May; 10(2):301-16. PubMed ID: 1584174
[TBL] [Abstract][Full Text] [Related]
2. Chapter 33: the history of movement disorders.
Lanska DJ
Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
[TBL] [Abstract][Full Text] [Related]
3. [Drug therapy in Parkinson's disease].
van Hilten JJ; Roos RA
Ned Tijdschr Geneeskd; 1999 Jan; 143(5):234-40. PubMed ID: 10086151
[TBL] [Abstract][Full Text] [Related]
4. Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness.
Hornykiewicz O
Neurodegener Dis; 2008; 5(3-4):114-7. PubMed ID: 18322366
[TBL] [Abstract][Full Text] [Related]
5. The history of dopamine and levodopa in the treatment of Parkinson's disease.
Fahn S
Mov Disord; 2008; 23 Suppl 3():S497-508. PubMed ID: 18781671
[TBL] [Abstract][Full Text] [Related]
6. [Short history of L-Dopa].
García Ruiz PJ; Meseguer E
Neurologia; 2002 Apr; 17(4):214-7. PubMed ID: 11940409
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease. A half century of progress.
Jankovic J
Neurology; 2001 Nov; 57(10 Suppl 3):S1-3. PubMed ID: 11771154
[No Abstract] [Full Text] [Related]
8. Substantia nigra and Parkinson's disease: a brief history of their long and intimate relationship.
Parent M; Parent A
Can J Neurol Sci; 2010 May; 37(3):313-9. PubMed ID: 20481265
[TBL] [Abstract][Full Text] [Related]
9. Interactions of exogenous L-dopa with nigrostriatal dopaminergic neurons in Parkinson's disease.
Melamed E
Adv Neurol; 1990; 53():61-6. PubMed ID: 2173376
[No Abstract] [Full Text] [Related]
10. [L-dopa-resistant parkinsonism with cerebral atrophy: striato-nigral degeneration? 2 cases].
Dell'Aria V; Ciannella L; Melone MA
Acta Neurol (Napoli); 1981 Feb; 3(1):212-5. PubMed ID: 7246294
[No Abstract] [Full Text] [Related]
11. The history of drugs for the treatment of Parkinson's disease.
Kapp W
J Neural Transm Suppl; 1992; 38():1-6. PubMed ID: 1491242
[TBL] [Abstract][Full Text] [Related]
12. [L-dopa-resistant Parkinson's disease with cerebral atrophy: striato-nigral degeneration?].
Dell'Aria V; Ciannella L; Melone MA
Acta Neurol Quad (Napoli); 1981; 42():212-5. PubMed ID: 7270052
[No Abstract] [Full Text] [Related]
13. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.
Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN
Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?
Agid Y; Graybiel AM; Ruberg M; Hirsch E; Blin J; Dubois B; Javoy-Agid F
Adv Neurol; 1990; 53():83-100. PubMed ID: 1978522
[No Abstract] [Full Text] [Related]
15. Dopamine and Parkinson's disease. A personal view of the past, the present, and the future.
Hornykiewicz O
Adv Neurol; 2001; 86():1-11. PubMed ID: 11553966
[No Abstract] [Full Text] [Related]
16. [Historical background of Parkinson's disease: on cellular degeneration of the substantia nigra].
Tanaka J; Fukuda T
Nihon Naika Gakkai Zasshi; 1994 Apr; 83(4):528-32. PubMed ID: 7963984
[No Abstract] [Full Text] [Related]
17. Two hundred steps.
Drew L
Nature; 2016 Oct; 538(7626):S2-S3. PubMed ID: 27783577
[No Abstract] [Full Text] [Related]
18. Parkinson's disease over the last 20 years: a personal view.
Calne DB
Funct Neurol; 1988; 3(4):395-406. PubMed ID: 3072275
[No Abstract] [Full Text] [Related]
19. [Pulmonary circulation in the history of medicine].
Morpurgo M; Bergamaschini L
Ital Heart J Suppl; 2003 May; 4(5):363-7. PubMed ID: 12848073
[TBL] [Abstract][Full Text] [Related]
20. Tracheotomy: historical review.
Pratt LW; Ferlito A; Rinaldo A
Laryngoscope; 2008 Sep; 118(9):1597-606. PubMed ID: 18596476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
